whether the FDA needs to further restrict or ban the use of Rezulin (troglitazone) for diabetes

Pharmacy Technician's Letter includes:

• 12 issues every year, with brief articles about new meds and hot topics
• 120+ CE courses, including the popular CE-in-the-Letter
• Helpful, in-depth Technician Tutorials
• Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote